The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biomarker-driven assessment of immunochemotherapy with or without fruquintinib as first-line treatment for advanced gastric/GEJ adenocarcinoma: Initial clinical results and subgroup analysis from the MGC-FLORA study.
 
Xiaodong Zhu
No Relationships to Disclose
 
Chenchen Wang
No Relationships to Disclose
 
Mingzhu Huang
No Relationships to Disclose
 
Wanjing Feng
No Relationships to Disclose
 
Jieyun Zhang
No Relationships to Disclose
 
Yuedi Dai
No Relationships to Disclose
 
Qin Ding
No Relationships to Disclose
 
Ruiwen Liu
No Relationships to Disclose
 
Ziteng Li
No Relationships to Disclose